title: Improvement of intestinal absorption of forsythoside A and chlorogenic acid by different carboxymethyl chitosan and chito-oligosaccharide, application to Flos Lonicerae-Fructus Forsythiae herb couple preparations.
abstract: The current study aims to investigate the effect of chitosan derivatives on the intestinal absorption and bioavailabilities of forsythoside A (FTA) and Chlorogenic acid (CHA), the major active components in Flos Lonicerae-Fructus Forsythiae herb couple. Biopharmaceutics and pharmacokinetics properties of the two compounds have been characterized in vitro, in situ as well as in rats. Based on the identified biopharmaceutics characteristics of the two compounds, the effect of chitosan derivatives as an absorption enhancer on the intestinal absorption and pharmacokinetics of FTA and CHA in pure compound form as well as extract form were investigated in vitro, in situ and in vivo. Both FTA and CHA demonstrated very limited intestinal permeabilities, leading to oral bioavailabilities being only 0.50% and 0.13% in rats, respectively. Results from both in vitro, in situ as well as in vivo studies consistently indicated that Chito-oligosaccharide (COS) at dosage of 25 mg/kg could enhance intestinal permeabilities significantly as well as the in vivo bioavailabilities of both FTA and CHA than CMCs in Flos Lonicerae-Fructus Forsythiae herb couple preparations, and was safe for gastrointestine from morphological observation. Besides, treatment with Flos Lonicerae-Fructus Forsythiae herb couple preparations with COS at the dosage of 25 mg/kg prevented MDCK damage after influenza virus propagation, which was significantly better than control. The current findings not only identified the usefulness of COS for the improved delivery of Flos Lonicerae-Fructus Forsythiae preparations but also demonstrated the importance of biopharmaceutical characterization in the dosage form development of traditional Chinese medicine.
authors.affiliation: College of Pharmacy, Nan'jing University of Chinese Medicine, Nan'jing, People's Republic of China.
authors.forename: Wei
authors.initials: W
authors.lastname: Zhou
authors.forename: Haidan
authors.initials: H
authors.lastname: Wang
authors.forename: Xuanxuan
authors.initials: X
authors.lastname: Zhu
authors.forename: Jinjun
authors.initials: J
authors.lastname: Shan
authors.forename: Ailing
authors.initials: A
authors.lastname: Yin
authors.forename: Baochang
authors.initials: B
authors.lastname: Cai
authors.forename: Liuqing
authors.initials: L
authors.lastname: Di
mesh_terms: D000818:Animals; D001682:Biological Availability; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D048271:Chitosan / Q000031:analogs & derivatives* / Q000494:pharmacology; D002726:Chlorogenic Acid / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics*; D004365:Drugs, Chinese Herbal / Q000378:metabolism / Q000493:pharmacokinetics*; D031657:Forsythia / Q000737:chemistry*; D006027:Glycosides / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects* / Q000502:physiology; D031239:Lonicera / Q000737:chemistry*; D008297:Male; D009844:Oligosaccharides / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D004365:Drugs, Chinese Herbal; D006027:Glycosides; D009844:Oligosaccharides; C514968:carboxymethyl-chitosan; D002726:Chlorogenic Acid; D048271:Chitosan; C058049:forsythiaside